And Artemis 3, a crewed moon landing that had been targeted for late 2026, is now scheduled for mid-2027. The extra time is needed primarily to finish prepping the Orion capsule for its first-ever ...

Ixo-vec is a potential best-in-class one-time gene therapy designed to deliver long-term efficacy, reduce the burden of frequent anti-VEGF and ...